Related Experiment Videos
Antinuclear antibodies.
1Division of Connective Tissue Disease and Autoimmunity, Department of Dermatology Nagoya University Graduate School of Medicine 65 Tsurumai-cho, Showa-ku Nagoya 466-8550 Japan. ymuro@med.nagoya-u.ac.jp
Autoimmunity
|April 5, 2005
Summary
Abnormal autoantibodies targeting intracellular antigens signal systemic connective tissue diseases. The indirect immunofluorescence assay detects antinuclear antibodies, with reviewed patterns and clinical application pitfalls.
Area of Science:
- Immunology
- Clinical Chemistry
Background:
- Autoantibodies to intracellular antigens are key indicators of systemic connective tissue diseases.
- The indirect immunofluorescence assay is the standard method for detecting antinuclear antibodies.
Purpose of the Study:
- To review representative fluorescence patterns in antinuclear antibody testing.
- To discuss potential pitfalls in applying these results to clinical practice.
Main Methods:
- Indirect immunofluorescence assay for antinuclear antibody detection.
- Review of characteristic fluorescence patterns.
- Analysis of clinical application challenges.
Main Results:
- Specific fluorescence patterns correlate with different connective tissue diseases.
- Misinterpretation of patterns can lead to diagnostic errors.
- Understanding pitfalls is crucial for accurate diagnosis.
Conclusions:
- Indirect immunofluorescence is vital for diagnosing connective tissue diseases.
- Accurate interpretation of antinuclear antibody patterns improves patient outcomes.
- Awareness of assay limitations enhances clinical utility.